Wim Tissing

Prof. dr. Wim Tissing is a Professor at the Faculty of Medical Sciences, University of Groningen, affiliated with the Innovative Clinical Studies and Long-term Treatment Consequences in Cancer (InClinS) group. His research focuses on pediatric oncology, with a particular emphasis on long-term treatment effects in childhood cancer survivors, supportive care, and clinical trial design. He contributes to UN Sustainable Development Goals related to health and well-being.

Research interests include childhood cancer, oncology, hematological disorders (e.g., acute lymphoblastic leukemia), and survivorship outcomes such as metabolic syndrome. His work integrates clinical practice guidelines and translational research.

Recent publications highlight interventions for cancer-related side effects (e.g., taste/smell changes, fever management) and advancements in stem cell mobilization. Collaborations span international studies on pediatric cancer survivorship and infection prevention.

Prof. Tissing leads the InClinS group and chairs IPOG since 2018. He has contributed to datasets on methotrexate-induced mucositis and has been featured in media for studies on overweight trends in pediatric cancer survivors.